m+Medelevator.RU
← Поиск публикаций
Discover oncology · 2026

Spatially resolved single cell analysis suggests an APOE NCF1 associated immunosuppressive niche and its prognostic signature in thyroid cancer.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Su Han, Zhang Zheng, Li Nuo, Zhang Zimo, Zhang Renju, Li Ziyi, Chen Fen, Wang Xinyue, Zhang Shuyuan, Zhang Chao

Аннотация

BACKGROUND: Thyroid carcinoma (TC) presents a rising global incidence, with a subset of cases progressing aggressively despite standard therapies. The tumor microenvironment (TME), particularly the functional state of CD8⁺ T cells, is crucial in disease progression, yet a systematic, high-resolution understanding of the cellular interactions associated with immune exhaustion and tumor evolution in TC remains limited.

METHODS: To address this, we performed an integrated single-cell and spatial transcriptomic analysis of human TC samples. Our approach combined scRNA-seq data processing, cell communication inference, spatial co-localization validation, and machine learning-based prognostic modeling.

RESULT: We identified a distinct tumor cell subcluster (Trem/T01) characterized by APOE expression and a CD8⁺ exhausted T cell (Tex) subset. Computational and spatial analyses revealed a potential APOE (from Trem)-NCF1 (from CD8⁺ Tex) interaction axis, with these cell types demonstrating significant spatial proximity in tumor tissues. Furthermore, we derived a prognostic gene signature from this network, constructing a robust risk stratification model validated across independent cohorts.

CONCLUSION: This study uniquely delineates a specific tumor-immune interactive niche in TC, providing insights into potential mechanisms into immune evasion via the APOE-NCF1 axis and delivering a translatable framework for patient prognostication.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты